SCHEMBL18258692

SCHEMBL18258692

O=c1[nH]c(-c2cc(Cl)ccc2O)nc2cc(Cl)ccc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GUSB P08236 7/20 0.59
KDM4E B2RXH2 2/20 0.57
HPGD P15428 2/20 0.57
MEN1 O00255 1/20 0.55
MAPT P10636 1/20 0.55
HTT P42858 1/20 0.55
KMT2A Q03164 1/20 0.55
HDAC6 Q9UBN7 1/20 0.51
TUBB4A P04350 1/20 0.47
TUBB P07437 1/20 0.47
TUBA3C P0DPH7 1/20 0.47
TUBA1B P68363 1/20 0.47
TUBA4A P68366 1/20 0.47
TUBB4B P68371 1/20 0.47
TUBB3 Q13509 1/20 0.47
TUBB2A Q13885 1/20 0.47
TUBB8 Q3ZCM7 1/20 0.47
TUBA3E Q6PEY2 1/20 0.47
TUBA1A Q71U36 1/20 0.47
TUBA1C Q9BQE3 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18258704 0.93 GUSB (0.60) GUSBKDM4EHPGDMEN1MAPT
SCHEMBL31710757 0.89 GUSB (0.76) GUSBKDM4EHPGDHDAC6TNKS
SCHEMBL18258694 0.89 GUSB (0.76) GUSBKDM4EHPGDHDAC6TNKS
SCHEMBL2370223 0.89 GUSB (0.59) GUSBKDM4EHPGDMEN1MAPT
SCHEMBL29890298 0.89 GUSB (0.59) GUSBKDM4EHPGDMEN1MAPT
Phosphoric Acid SCHEMBL3658256 0.84 GUSB (0.54) GUSBKDM4EHPGDMEN1MAPT
Phosphoric Acid SCHEMBL3660040 0.83 GUSB (0.53) GUSBKDM4EHPGDMEN1MAPT
Phosphoric Acid SCHEMBL3660043 0.82 GUSB (0.52) GUSBKDM4EHPGDMEN1MAPT
SCHEMBL18258699 0.82 GUSB (0.78) GUSBKDM4EHPGDMAPTTNKS
SCHEMBL31066915 0.81 GUSB (0.60) GUSBKDM4EHPGDMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170012218-A1 NEAR-ULTRAVIOLET STIMULATED LIGHT-EMITTING COMPOUND AND PRODUCTION METHOD FOR SAME NANO CMS CO., LTD. (KR) 2017-01-12 US claimed
EP-3098284-A1 NEAR-ULTRAVIOLET STIMULATED LIGHT-EMITTING COMPOUND AND PRODUCTION METHOD FOR SAME Nano CMS Co., Ltd. (KR) 2016-11-30 EP claimed
EP-3098284-B1 NEAR-ULTRAVIOLET STIMULATED LIGHT-EMITTING COMPOUND AND PRODUCTION METHOD FOR SAME NANO CMS CO LTD (KR) 2024-09-04 EP disclosed
US-20170012218-A1 NEAR-ULTRAVIOLET STIMULATED LIGHT-EMITTING COMPOUND AND PRODUCTION METHOD FOR SAME NANO CMS CO., LTD. (KR) 2017-01-12 US disclosed
US-20170012218-A1 NEAR-ULTRAVIOLET STIMULATED LIGHT-EMITTING COMPOUND AND PRODUCTION METHOD FOR SAME NANO CMS CO., LTD. (KR) 2017-01-12 US disclosed
US-20170012218-A1 NEAR-ULTRAVIOLET STIMULATED LIGHT-EMITTING COMPOUND AND PRODUCTION METHOD FOR SAME NANO CMS CO., LTD. (KR) 2017-01-12 US disclosed
EP-3098284-A1 NEAR-ULTRAVIOLET STIMULATED LIGHT-EMITTING COMPOUND AND PRODUCTION METHOD FOR SAME Nano CMS Co., Ltd. (KR) 2016-11-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170012218-A1 NEAR-ULTRAVIOLET STIMULATED LIGHT-EMITTING COMPOUND AND PRODUCTION METHOD FOR SAME SUN2, TYR, SQLE GUSB 1639/4885KDM4E 1890/4885HPGD 168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.